Breast Carcinoma by Gene Expression Profile

Breast Carcinoma by Gene Expression Profile — Trials · CancerIndex

Clinical trials

Registered studies

1,299 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 537
Recruiting: 296
Ph III recruiting: 38
Growth YoY: +1.9%
Industry share: 28%
Top sponsor: Fudan University
Termination share: 46%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (217)

clinicaltrialsPublishedShowing 51–100 of 336 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06460298	ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer	recruiting	Phase 1 / Phase 2	51	ProDa BioTech, LLCINDUSTRY	1	Aug 31, 2026	clinicaltrials
NCT04677816	Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients	recruiting	Phase 2	50	Wake Forest University Health SciencesOTHER	1	Aug 28, 2026	clinicaltrials